Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ampersand Capital Partners

Founders Richard A. Charpie

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 74
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 56
Rounds per year 2.06
Lead investments 25
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.24
Exits 28
Key employees 11
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Medical
Summary

The leading representative office of defined VC is situated in the Wellesley. The fund was located in North America if to be more exact in United States.

The higher amount of exits for fund were in 2017. The fund is constantly included in 2-6 investment rounds annually. The average startup value when the investment from Ampersand Capital Partners is 100-500 millions dollars. The real fund results show that this VC is 25 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Ampersand Capital Partners works on 6 percentage points more the average amount of lead investments. The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FirstRain, Endeca, Ensemble Communications. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Life Science, Medical. The fund has exact preference in a number of founders of portfolio startups.

This organization was formed by Richard A. Charpie. We also calculated 11 valuable employees in our database.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Ampersand Capital Partners, startups are often financed by Diamondhead Ventures, Venrock, Star Ventures. The meaningful sponsors for the fund in investment in the same round are Diamondhead Ventures, Venrock, Oak Investment Partners. In the next rounds fund is usually obtained by Oak Investment Partners, Venrock, GGV Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Ampersand Capital Partners:
Typical Co-investors
Ampersand Capital Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Ampersand Capital Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Vernal Biosciences

$20M27 Jun 2023 Burlington, Vermont, United States

AnaBios

Biotechnology
Drug Discovery
Media and Information Services (B2B)
Medical
Pharmaceutical
Pharmaceuticals
$6M07 Jun 2022 San Diego, California, United States

Vernal Biosciences

$21M02 Jun 2022 Burlington, Vermont, United States

Arranta Bio

Biotechnology
08 Mar 2021 Massachusetts, United States

Canopy Biosciences

Biopharma
Biotechnology
Health Care
Life Science
01 Jan 2017 City of Saint Louis, Missouri, United States

Biopharma
Biotechnology
Pharmaceutical
01 Jan 2013 Worcester, Massachusetts, United States

RadPharm

Health Care
Image Recognition
Medical
$10M28 Nov 2007 Belconnen, Australian Capital Territory, Australia

Cequent Pharmaceuticals

Biotechnology
Health Care
Therapeutics
$9M18 Jun 2007 Cambridge, Massachusetts, United States

Assay Designs

Life Science
Manufacturing
Product Design
$5M13 May 2005 Ann Arbor, Michigan, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ampersand Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 74
Average round size 10M
Rounds per year 2.06
Peak activity year 2019
Lead investments 25
Follow on index 0.24
Exits 28
Group Appearance index 0.43

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Vernal Biosciences

$20M27 Jun 2023 Burlington, Vermont, United States

AnaBios

Biotechnology
Drug Discovery
Media and Information Services (B2B)
Medical
Pharmaceutical
Pharmaceuticals
$6M07 Jun 2022 San Diego, California, United States

Vernal Biosciences

$21M02 Jun 2022 Burlington, Vermont, United States

Arranta Bio

Biotechnology
08 Mar 2021 Massachusetts, United States

Canopy Biosciences

Biopharma
Biotechnology
Health Care
Life Science
01 Jan 2017 City of Saint Louis, Missouri, United States

Biopharma
Biotechnology
Pharmaceutical
01 Jan 2013 Worcester, Massachusetts, United States

RadPharm

Health Care
Image Recognition
Medical
$10M28 Nov 2007 Belconnen, Australian Capital Territory, Australia

Cequent Pharmaceuticals

Biotechnology
Health Care
Therapeutics
$9M18 Jun 2007 Cambridge, Massachusetts, United States

Assay Designs

Life Science
Manufacturing
Product Design
$5M13 May 2005 Ann Arbor, Michigan, United States
Crunchbase icon

Content report

The following text will be sent to our editors: